Cephalosporin Drugs Market, By Generation (First-generation, Cephalosporin, Second-generation Cephalosporin, Third-generation Cephalosporin, Fourth-generation Cephalosporin, and Fifth-generation Cephalosporin), By Type (Branded Cephalosporin Drugs and Gen

Cephalosporin Drugs Market, By Generation (First-generation, Cephalosporin, Second-generation Cephalosporin, Third-generation Cephalosporin, Fourth-generation Cephalosporin, and Fifth-generation Cephalosporin), By Type (Branded Cephalosporin Drugs and Generic Cephalosporin Drugs), By Formulation (Oral (Tablets, Capsules, and Liquid) and Injection), By Indication (Respiratory Tract Infection, Skin Infection, Ear Infection, Bacterial Infection, Urinary Tract Infection, Sexually Transmitted Infection, Sinus Infection, Surgical Prophylaxis, and Others (Meningitis, Acute Abdomen Infection, and Pelvic infection)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Trends, and Forecast 2019 - 2026

Cephalosporin drugs are a group of broad-spectrum, semi-synthetic beta-lactam antibiotics generally used for the treatment of bacterial infections such as bacterial meningitis, otitis media, pneumonia, tuberculosis, upper respiratory tract infection, eye infections, sinusitis, urinary tract infections, skin infections, and sexually transmitted diseases. Most commonly used cephalosporin are cephalexin, ceftriaxone, cefixime, cefdinir, and cefaclor. The cephalosporin drugs market holds a huge potential in the sub-Saharan countries of Africa such as Ethiopia, Ghana, Nigeria, and Senegal, as these countries have high prevalence of bacterial infections due to underdeveloped healthcare facilities and infrastructure. For instance, according to the World Health Organization’s (WHO) report of February 2018, the highest burden of this disease is in the belt of sub-Saharan Africa, stretching from Senegal in the west to Ethiopia in the east. Around 30,000 cases are still reported each year from that area.

Market Dynamics

Increasing prevalence of respiratory tract infections worldwide is expected to boost the cephalosporin drugs market growth. For instance, according to the report of The Global Impact of Respiratory Disease in 2017, lower respiratory tract infection and pneumonia are two of the leading causes of death, accounting for over 4 million fatalities, annually. Furthermore, pneumonia killed 920,136 children aged under 5 years in 2015, accounting for 15% of the deaths in this age group. Streptococcus pneumoniae remains the most frequent bacterial cause of pneumonia, accounting for deaths of 393,000 children aged under 5 years in 2015.

However, factors such as increasing Food and Drug Administration (FDA) recalls is hindering the cephalosporin drugs market growth. For instance, in June 2019, Lupin Limited recalled 18,604 bottles (60 ml) of Cefdinir (Cephalosporin) for Oral Suspension, used for the treatment of bacterial infections, from the U.S. market. Furthermore, in January 2019, the company announced recall of 287,784 bottles of Cefdinir for Oral Suspension in the U.S. due to CGMP (Current Good Manufacturing Practice) deviations.

Key features of the study:

  • This report provides in-depth analysis of the cephalosporin drugs market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2019 – 2026, considering 2018 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global cephalosporin drugs market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include, Merck & Co. Inc., GlaxoSmithKline plc., Pfizer Inc., Allergan plc., Abbott Laboratories, Basilea Pharmaceutica Ltd., Sanofi S.A., F. Hoffmann-La Roche AG, Lupin Limited, Teva Pharmaceutical Industries Ltd., and B. Braun Melsungen AG
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global cephalosporin drugs market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for cephalosporin drugs market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
  • Global Cephalosporin Drugs Market, By Generation:
  • First-generation Cephalosporin
  • Second-generation Cephalosporin
  • Third-generation Cephalosporin
  • Fourth-generation Cephalosporin
  • Fifth-generation Cephalosporin
  • Global Cephalosporin Drugs Market, By Type:
  • Branded Cephalosporin Drugs
  • Generic Cephalosporin Drugs
  • Global Cephalosporin Drugs Market, By Formulation:
  • Oral
  • Tablets
  • Capsules
  • Liquid
  • Injection
  • Global Cephalosporin Drugs Market, By Indication:
  • Respiratory Tract Infection
  • Skin Infection
  • Ear Infection
  • Bacterial Infection
  • Urinary Tract Infection
  • Sexually Transmitted Infection
  • Sinus Infection
  • Surgical Prophylaxis
  • Others (Meningitis, Acute Abdomen Infection, and Pelvic Infection)
  • Global Cephalosporin Drugs Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Global Cephalosporin Drugs Market, By Region:
  • North America
  • By Country:
  • U.S.
  • Canada
  • By Generation:
  • First-generation Cephalosporin
  • Second-generation Cephalosporin
  • Third-generation Cephalosporin
  • Fourth-generation Cephalosporin
  • Fifth-generation Cephalosporin
  • By Type:
  • Branded Cephalosporin Drugs
  • Generic Cephalosporin Drugs
  • By Formulation:
  • Oral
  • Tablets
  • Capsules
  • Liquid
  • Injection
  • By Indication:
  • Respiratory Tract Infection
  • Skin Infection
  • Ear Infection
  • Bacterial Infection
  • Urinary Tract Infection
  • Sexually Transmitted Infection
  • Sinus Infection
  • Surgical Prophylaxis
  • Others (Meningitis, Acute Abdomen Infection, and Pelvic Infection)
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Europe
  • By Country:
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
  • By Generation:
  • First-generation Cephalosporin
  • Second-generation Cephalosporin
  • Third-generation Cephalosporin
  • Fourth-generation Cephalosporin
  • Fifth-generation Cephalosporin
  • By Type:
  • Branded Cephalosporin Drugs
  • Generic Cephalosporin Drugs
  • By Formulation:
  • Oral
  • Tablets
  • Capsules
  • Liquid
  • Injection
  • By Indication:
  • Respiratory Tract Infection
  • Skin Infection
  • Ear Infection
  • Bacterial Infection
  • Urinary Tract Infection
  • Sexually Transmitted Infection
  • Sinus Infection
  • Surgical Prophylaxis
  • Others (Meningitis, Acute Abdomen Infection, and Pelvic Infection)
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Asia Pacific
  • By Country:
  • Australia
  • India
  • China
  • Japan
  • ASEAN
  • South Korea
  • Rest of Asia Pacific
  • By Generation:
  • First-generation Cephalosporin
  • Second-generation Cephalosporin
  • Third-generation Cephalosporin
  • Fourth-generation Cephalosporin
  • Fifth-generation Cephalosporin
  • By Type:
  • Branded Cephalosporin Drugs
  • Generic Cephalosporin Drugs
  • By Formulation:
  • Oral
  • Tablets
  • Capsules
  • Liquid
  • Injection
  • By Indication:
  • Respiratory Tract Infection
  • Skin Infection
  • Ear Infection
  • Bacterial Infection
  • Urinary Tract Infection
  • Sexually Transmitted Infection
  • Sinus Infection
  • Surgical Prophylaxis
  • Others (Meningitis, Acute Abdomen Infection, and Pelvic Infection)
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Latin America
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • By Generation:
  • First-generation Cephalosporin
  • Second-generation Cephalosporin
  • Third-generation Cephalosporin
  • Fourth-generation Cephalosporin
  • Fifth-generation Cephalosporin
  • By Type:
  • Branded Cephalosporin Drugs
  • Generic Cephalosporin Drugs
  • By Formulation:
  • Oral
  • Tablets
  • Capsules
  • Liquid
  • Injection
  • By Indication:
  • Respiratory Tract Infection
  • Skin Infection
  • Ear Infection
  • Bacterial Infection
  • Urinary Tract Infection
  • Sexually Transmitted Infection
  • Sinus Infection
  • Surgical Prophylaxis
  • Others (Meningitis, Acute Abdomen Infection, and Pelvic Infection)
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Middle East
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • By Generation:
  • First-generation Cephalosporin
  • Second-generation Cephalosporin
  • Third-generation Cephalosporin
  • Fourth-generation Cephalosporin
  • Fifth-generation Cephalosporin
  • By Type:
  • Branded Cephalosporin Drugs
  • Generic Cephalosporin Drugs
  • By Formulation:
  • Oral
  • Tablets
  • Capsules
  • Liquid
  • Injection
  • By Indication:
  • Respiratory Tract Infection
  • Skin Infection
  • Ear Infection
  • Bacterial Infection
  • Urinary Tract Infection
  • Sexually Transmitted Infection
  • Sinus Infection
  • Surgical Prophylaxis
  • Others (Meningitis, Acute Abdomen Infection, and Pelvic Infection)
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Africa
  • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
  • By Generation:
  • First-generation Cephalosporin
  • Second-generation Cephalosporin
  • Third-generation Cephalosporin
  • Fourth-generation Cephalosporin
  • Fifth-generation Cephalosporin
  • By Type:
  • Branded Cephalosporin Drugs
  • Generic Cephalosporin Drugs
  • By Formulation:
  • Oral
  • Tablets
  • Capsules
  • Liquid
  • Injection
  • By Indication:
  • Respiratory Tract Infection
  • Skin Infection
  • Ear Infection
  • Bacterial Infection
  • Urinary Tract Infection
  • Sexually Transmitted Infection
  • Sinus Infection
  • Surgical Prophylaxis
  • Others (Meningitis, Acute Abdomen Infection, and Pelvic Infection)
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Company Profiles
  • Merck & Co. Inc.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • GlaxoSmithKline plc.
  • Pfizer Inc.
  • Allergan plc.
  • Abbott Laboratories
  • Basilea Pharmaceutica Ltd.
  • Sanofi S.A.
  • F. Hoffmann-La Roche AG
  • Lupin Limited
  • Teva Pharmaceutical Industries Ltd.
  • B. Braun Melsungen AG
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Overview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Generation
Market Snippet, By Type
Market Snippet, By Formulation
Market Snippet, By Indication
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Market Trends
Key Developments
Major Brand Analysis
Reimbursement Scenario
Epidemiology Analysis
Porter’s Five Forces Model
Pipeline Analysis
Switch Analysis
Site Chain Analysis
4. Global Cephalosporin Drugs Market
Antibiotic Resistance Trends By Country
5. Global Cephalosporin Drugs Market, By Generation, 2019 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2019 and 2026 (%)
Y-o-Y Growth Analysis, 2018 – 2026
Segment Trends
First-generation Cephalosporin
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
Second-generation Cephalosporin
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
Third-generation Cephalosporin
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
Fourth-generation Cephalosporin
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
Fifth-generation Cephalosporin
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
6. Global Cephalosporin Drugs Market, By Type, 2019 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2019 and 2026 (%)
Y-o-Y Growth Analysis, 2018 – 2026
Segment Trends
Branded Cephalosporin Drugs
Market Share Analysis, 2019 and 2026 (%)
Y-o-Y Growth Analysis, 2018 – 2026
Segment Trends
Generic Cephalosporin Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
7. Global Cephalosporin Drugs Market, By Formulation, 2019 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2019 and 2026 (%)
Y-o-Y Growth Analysis, 2018 – 2026
Segment Trends
Oral
Market Share Analysis, 2019 and 2026 (%)
Y-o-Y Growth Analysis, 2018 – 2026
Segment Trends
Tablets
Capsules
Liquid
Injection
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
8. Global Cephalosporin Drugs Market, By Indication, 2019 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2019 and 2026 (%)
Y-o-Y Growth Analysis, 2018 – 2026
Segment Trends
Respiratory Tract Infection
Market Share Analysis, 2019 and 2026 (%)
Y-o-Y Growth Analysis, 2018 – 2026
Segment Trends
Skin Infection
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
Ear Infection
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
Bacterial Infection
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
Urinary Tract Infection
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
Sexually Transmitted Infection
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
Sinus Infection
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
Surgical Prophylaxis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
Others (Meningitis, Acute Abdomen Infection, and Pelvic Infection)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
9. Global Cephalosporin Drugs Market, By Distribution Channel, 2019 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2019 and 2026 (%)
Y-o-Y Growth Analysis, 2018 – 2026
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
10. Global Cephalosporin Drugs Market, By Region, 2019 – 2026, (US$ Million)
Introduction
Market Share Analysis, By Region, 2019 and 2026 (%)
Y-o-Y Growth Analysis, By Region, 2018 – 2026
Regional Trends
North America
Market Size and Forecast, By Generation, 2019 – 2026, (US$ Million)
Market Size and Forecast, By Type, 2019 – 2026, (US$ Million)
Market Size and Forecast, By Formulation, 2019 – 2026, (US$ Million)
Market Size and Forecast, By Indication, 2019 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2019 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2019 – 2026, (US$ Million)
U.S.
Canada
Europe
Market Size and Forecast, By Generation, 2019 – 2026, (US$ Million)
Market Size and Forecast, By Type, 2019 – 2026, (US$ Million)
Market Size and Forecast, By Formulation, 2019 – 2026, (US$ Million)
Market Size and Forecast, By Indication, 2019 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2019 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2019 – 2026, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Generation, 2019 – 2026, (US$ Million)
Market Size and Forecast, By Type, 2019 – 2026, (US$ Million)
Market Size and Forecast, By Formulation, 2019 – 2026, (US$ Million)
Market Size and Forecast, By Indication, 2019 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2019 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2019 – 2026, (US$ Million)
China
Japan
India
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Market Size and Forecast, By Generation, 2019 – 2026, (US$ Million)
Market Size and Forecast, By Type, 2019 – 2026, (US$ Million)
Market Size and Forecast, By Formulation, 2019 – 2026, (US$ Million)
Market Size and Forecast, By Indication, 2019 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2019 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2019 – 2026, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Africa
Market Size and Forecast, By Generation, 2019 – 2026, (US$ Million)
Market Size and Forecast, By Type, 2019 – 2026, (US$ Million)
Market Size and Forecast, By Formulation, 2019 – 2026, (US$ Million)
Market Size and Forecast, By Indication, 2019 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2019 – 2026, (US$ Million)
Market Size and Forecast, By Country/Region, 2019 – 2026, (US$ Million)
North Africa
Central Africa
South Africa
Middle East
Market Size and Forecast, By Generation, 2019 – 2026, (US$ Million)
Market Size and Forecast, By Type, 2019 – 2026, (US$ Million)
Market Size and Forecast, By Formulation, 2019 – 2026, (US$ Million)
Market Size and Forecast, By Indication, 2019 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2019 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2019 – 2026, (US$ Million)
GCC Countries
Israel
Rest of Middle East
11. Competitive Landscape
Company Profiles
Merck & Co. Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
GlaxoSmithKline plc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Pfizer Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Allergan plc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Abbott Laboratories
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Basilea Pharmaceutica Ltd.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Sanofi S.A.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
F. Hoffmann-La Roche AG
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Lupin Limited
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Teva Pharmaceutical Industries Ltd.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
B. Braun Melsungen AG
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Analyst Views
12. Section
References
Research Methodology
About Us and Sales Contact
*Browse 53 market data tables and 50 figures on "Cephalosporin Drugs Market” - Global forecast to 2026”

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook